FDA Pilot Aims to Reduce Risk of Diagnostic Tests for Cancer
The FDA expressed concern that some laboratory-developed tests may not be as reliable or perform as well as FDA-authorized tests. The pilot program will provide more scrutiny of these tests.
Medscape Medical News
source https://www.medscape.com/viewarticle/993801?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/993801?src=rss
Comments
Post a Comment